Perioperative considerations in free flap surgery: A review of pressors and anticoagulation

Mark Wax, James Azzi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Given the high stakes for microvascular reconstruction, the majority of reconstructive surgeons have developed paradigms for pre, intra, and postoperative management that have proven to result in individual high success rates. Much has been done to identify and avoid perioperative factors that could potentially increase flap failure rates. Two example of this practice has been the generalized use of anticoagulation in free tissue transfer and the prohibition against vasopressor use in patients that are undergoing free tissue transfer. This manuscript will discuss these issues.

Original languageEnglish (US)
Pages (from-to)154-157
Number of pages4
JournalOral Oncology
Volume83
DOIs
StatePublished - Aug 1 2018

Fingerprint

Free Tissue Flaps
Surgeons

Keywords

  • Anticoagulation
  • Head and neck cancer
  • Microvascular reconstruction
  • Reconstruction
  • Vassopressor

ASJC Scopus subject areas

  • Oral Surgery
  • Oncology
  • Cancer Research

Cite this

Perioperative considerations in free flap surgery : A review of pressors and anticoagulation. / Wax, Mark; Azzi, James.

In: Oral Oncology, Vol. 83, 01.08.2018, p. 154-157.

Research output: Contribution to journalArticle

@article{505dc0ba16e54fe08393c01112b002bd,
title = "Perioperative considerations in free flap surgery: A review of pressors and anticoagulation",
abstract = "Given the high stakes for microvascular reconstruction, the majority of reconstructive surgeons have developed paradigms for pre, intra, and postoperative management that have proven to result in individual high success rates. Much has been done to identify and avoid perioperative factors that could potentially increase flap failure rates. Two example of this practice has been the generalized use of anticoagulation in free tissue transfer and the prohibition against vasopressor use in patients that are undergoing free tissue transfer. This manuscript will discuss these issues.",
keywords = "Anticoagulation, Head and neck cancer, Microvascular reconstruction, Reconstruction, Vassopressor",
author = "Mark Wax and James Azzi",
year = "2018",
month = "8",
day = "1",
doi = "10.1016/j.oraloncology.2018.06.025",
language = "English (US)",
volume = "83",
pages = "154--157",
journal = "Oral Oncology",
issn = "1368-8375",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Perioperative considerations in free flap surgery

T2 - A review of pressors and anticoagulation

AU - Wax, Mark

AU - Azzi, James

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Given the high stakes for microvascular reconstruction, the majority of reconstructive surgeons have developed paradigms for pre, intra, and postoperative management that have proven to result in individual high success rates. Much has been done to identify and avoid perioperative factors that could potentially increase flap failure rates. Two example of this practice has been the generalized use of anticoagulation in free tissue transfer and the prohibition against vasopressor use in patients that are undergoing free tissue transfer. This manuscript will discuss these issues.

AB - Given the high stakes for microvascular reconstruction, the majority of reconstructive surgeons have developed paradigms for pre, intra, and postoperative management that have proven to result in individual high success rates. Much has been done to identify and avoid perioperative factors that could potentially increase flap failure rates. Two example of this practice has been the generalized use of anticoagulation in free tissue transfer and the prohibition against vasopressor use in patients that are undergoing free tissue transfer. This manuscript will discuss these issues.

KW - Anticoagulation

KW - Head and neck cancer

KW - Microvascular reconstruction

KW - Reconstruction

KW - Vassopressor

UR - http://www.scopus.com/inward/record.url?scp=85049109027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049109027&partnerID=8YFLogxK

U2 - 10.1016/j.oraloncology.2018.06.025

DO - 10.1016/j.oraloncology.2018.06.025

M3 - Article

AN - SCOPUS:85049109027

VL - 83

SP - 154

EP - 157

JO - Oral Oncology

JF - Oral Oncology

SN - 1368-8375

ER -